BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MALAT1, PRO1073, 378938, Q9UHZ2
32 results:

  • 1. Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic leukemia.
    Tomic Vujovic K; Ugrin M; Tosic N; Vukovic V; Marjanovic I; Kostic T; Stankovic S; Otasevic V; Sarac S; Antic D; Pavlovic S; Karan-Djurasevic T
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255996
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. malat1 expression is associated with aggressive behavior in indolent B-cell neoplasms.
    Fernández-Garnacho EM; Nadeu F; Martín S; Mozas P; Rivero A; Delgado J; Giné E; López-Guillermo A; Duran-Ferrer M; Salaverria I; López C; Beà S; Demajo S; Jares P; Puente XS; Martín-Subero JI; Campo E; Hernández L
    Sci Rep; 2023 Oct; 13(1):16839. PubMed ID: 37803049
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid leukemia.
    Li Y; Kan X
    Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Haplotype-GGGT in long non-coding RNA malat1 inhibits brain metastatic lung cancer and lymph nodes of lung cancer via the malat1/miR-328/KATNB1.
    Liu T; Ma J; Hou D; Wang W; Cao H
    Aging (Albany NY); 2023 Mar; 15(6):1918-1930. PubMed ID: 36934373
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1.
    Jin J; Fu L; Hong P; Feng W
    Acta Biochim Pol; 2023 Feb; 70(1):37-43. PubMed ID: 36812496
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epigenetic silencing of E-cadherin gene induced by lncRNA MALAT-1 in acute myeloid leukaemia.
    Huang J; Fang J; Chen Q; Chen J; Shen J
    J Clin Lab Anal; 2022 Aug; 36(8):e24556. PubMed ID: 35747989
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Expression of LncRNA-malat1 in Peripheral Blood of Patients with Acute Myeloid leukemia Sepsis and Its Clinical Significance].
    Zeng SY; Lyu M; Yuan J; Hu YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1763-1767. PubMed ID: 34893107
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [The Effect of MicroRNA-143 on the Proliferation and Apoptosis of leukemia Cell Line U-937].
    Huang JL; Fang JP; Shen JZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1695-1703. PubMed ID: 34893096
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exploring the expression profile of vitamin D receptor and its related long non-coding RNAs in patients with acute lymphoblastic leukemia.
    Norouzi A; Motaghi M; Hassanshahi G; Nazari-Robati M
    Rev Assoc Med Bras (1992); 2021 Aug; 67(8):1113-1117. PubMed ID: 34669855
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long non-coding RNA malat1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia.
    Sheng XF; Hong LL; Li H; Huang FY; Wen Q; Zhuang HF
    Hematology; 2021 Dec; 26(1):43-52. PubMed ID: 33382018
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Systematic analysis reveals a lncRNA-miRNA-mRNA network associated with dasatinib resistance in chronic myeloid leukemia.
    Luo J; Gao Y; Lin X; Guan X
    Ann Palliat Med; 2021 Feb; 10(2):1727-1738. PubMed ID: 33302634
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exercise-mediated downregulation of malat1 expression and implications in primary and secondary cancer prevention.
    Paronetto MP; Dimauro I; Grazioli E; Palombo R; Guidotti F; Fantini C; Sgrò P; De Francesco D; Di Luigi L; Capranica L; Caporossi D
    Free Radic Biol Med; 2020 Nov; 160():28-39. PubMed ID: 32768573
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LncRNA-malat1 regulates proliferation and apoptosis of acute lymphoblastic leukemia cells via miR-205-PTK7 pathway.
    Song Y; Guo NH; Zheng JF
    Pathol Int; 2020 Oct; 70(10):724-732. PubMed ID: 32754978
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies.
    Chen ZH; Chen TQ; Zeng ZC; Wang D; Han C; Sun YM; Huang W; Sun LY; Fang K; Chen YQ; Luo XQ; Wang WT
    Cell Death Dis; 2020 Jul; 11(7):566. PubMed ID: 32703936
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. LncRNA malat1 Enhances ox-LDL-Induced Autophagy through the SIRT1/MAPK/NF-κB Pathway in Macrophages.
    Yang J; Lin X; Wang L; Sun T; Zhao Q; Ma Q; Zhou Y
    Curr Vasc Pharmacol; 2020; 18(6):652-662. PubMed ID: 32183682
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of long non-coding RNA and leukemia: A systematic review.
    Dieter C; Lourenco ED; Lemos NE
    Gene; 2020 Apr; 735():144405. PubMed ID: 32014562
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.
    Ghafouri-Fard S; Ashrafi Hafez A; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104330. PubMed ID: 31712117
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transcript-level regulation of malat1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CCL21 Induces mTOR-dependent malat1 Expression, Leading to Cell Migration in Cutaneous T-Cell Lymphoma.
    Hong CH; Lin SH; Lee CH
    In Vivo; 2019; 33(3):793-800. PubMed ID: 31028199
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. malat1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells.
    Hu N; Chen L; Wang C; Zhao H
    Biomed Pharmacother; 2019 Apr; 112():108720. PubMed ID: 30970520
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.